142 related articles for article (PubMed ID: 33434702)
1. Bioinformatics features and immunogenic epitopes of Echinococcus granulosus Myophilin as a promising target for vaccination against cystic echinococcosis.
Shams M; Javanmardi E; Nosrati MC; Ghasemi E; Shamsinia S; Yousefi A; Kordi B; Majidiani H; Nourmohammadi H
Infect Genet Evol; 2021 Apr; 89():104714. PubMed ID: 33434702
[TBL] [Abstract][Full Text] [Related]
2. Combining proteomics and bioinformatics to explore novel tegumental antigens as vaccine candidates against Echinococcus granulosus infection.
Miles S; Portela M; Cyrklaff M; Ancarola ME; Frischknecht F; Durán R; Dematteis S; Mourglia-Ettlin G
J Cell Biochem; 2019 Sep; 120(9):15320-15336. PubMed ID: 31038784
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of EgA31 and EgG1Y162 proteins for designing a multi-epitope vaccine against Echinococcus granulosus.
Zhao X; Zhang F; Li Z; Wang H; An M; Li Y; Pang N; Ding J
Infect Genet Evol; 2019 Sep; 73():98-108. PubMed ID: 31022474
[TBL] [Abstract][Full Text] [Related]
4.
Khazaei S; Dalimi A; Pirestani M; Ghafarifar F
Arch Razi Inst; 2023 Feb; 78(1):323-335. PubMed ID: 37312723
[TBL] [Abstract][Full Text] [Related]
5. Design of a Novel Multi-Epitope Vaccine Against
Yu M; Zhu Y; Li Y; Chen Z; Sha T; Li Z; Zhang F; Ding J
Front Immunol; 2021; 12():668492. PubMed ID: 34456902
[TBL] [Abstract][Full Text] [Related]
6. Biochemical Properties and Immunogenic Epitopes of
Khazaei S; Dalimi A; Pirestani M; Ghafarifar F
Iran J Parasitol; 2024; 19(1):61-74. PubMed ID: 38654954
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii ROP38 protein: Bioinformatics analysis for vaccine design improvement against toxoplasmosis.
Nosrati MC; Ghasemi E; Shams M; Shamsinia S; Yousefi A; Nourmohammadi H; Javanmardi E; Kordi B; Majidiani H; Ghaffari AD; Shakarami F
Microb Pathog; 2020 Dec; 149():104488. PubMed ID: 32916240
[TBL] [Abstract][Full Text] [Related]
8. A novel in silico minigene vaccine based on CD4
Pourseif MM; Moghaddam G; Naghili B; Saeedi N; Parvizpour S; Nematollahi A; Omidi Y
Comput Biol Chem; 2018 Feb; 72():150-163. PubMed ID: 29195784
[TBL] [Abstract][Full Text] [Related]
9. Variability of the
Sreevatsava V; De S; Bandyopadhyay S; Chaudhury P; Bera AK; Muthiyan R; De AK; Perumal P; Sunder J; Chakraborty G; Bhattacharya D
J Genet; 2019 Jun; 98(2):. PubMed ID: 31204707
[TBL] [Abstract][Full Text] [Related]
10. Immunoinformatic Analysis of Leishmania Major gp46 Protein and Potential Targets for Vaccination against Leishmaniasis.
Hafezi Ahmadi MR; Mamizadeh M; Siamian D; Touyeh MAA; Shams M; Rashidi Y
Recent Adv Inflamm Allergy Drug Discov; 2024 Feb; ():. PubMed ID: 38318831
[TBL] [Abstract][Full Text] [Related]
11. In silico cloning and B/T cell epitope prediction of triosephosphate isomerase from Echinococcus granulosus.
Wang F; Ye B
Parasitol Res; 2016 Oct; 115(10):3991-8. PubMed ID: 27283960
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii.
Foroutan M; Ghaffarifar F; Sharifi Z; Dalimi A; Pirestani M
Infect Genet Evol; 2018 Aug; 62():193-204. PubMed ID: 29705360
[TBL] [Abstract][Full Text] [Related]
13. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.
Alvarez Rojas CA; Gauci CG; Lightowlers MW
Parasite Immunol; 2013 Feb; 35(2):99-102. PubMed ID: 23009356
[TBL] [Abstract][Full Text] [Related]
14. Immunoproteomics approach for EPC1 antigenic epitope prediction of G1 and G6 strains of Echinococcus granulosus.
Etebar F; Jalousian F; Hosseini SH; Kordafshari S; Najafi A
Parasitol Res; 2013 Sep; 112(9):3129-35. PubMed ID: 23783398
[TBL] [Abstract][Full Text] [Related]
15. Immunization of mice with egG1Y162-1/2 provides protection against Echinococcus granulosus infection in BALB/c mice.
Zhang F; Li S; Zhu Y; Zhang C; Li Y; Ma H; Pang N; An M; Wang H; Ding J
Mol Immunol; 2018 Feb; 94():183-189. PubMed ID: 29328998
[TBL] [Abstract][Full Text] [Related]
16. Computational probing of Toxoplasma gondii major surface antigen 1 (SAG1) for enhanced vaccine design against toxoplasmosis.
Majidiani H; Dalimi A; Ghaffarifar F; Pirestani M; Ghaffari AD
Microb Pathog; 2020 Oct; 147():104386. PubMed ID: 32663606
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic prediction of the antigenic epitopes of recombinant ferritin of Echinococcus granulosus.
Liu X; Zhao H; Cao W; Liu Y; Zhang C; Lan X; Peng S; Wen H; Ding J; Ma X
Mol Med Rep; 2016 Jan; 13(1):888-94. PubMed ID: 26648019
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice.
Foroutan M; Ghaffarifar F; Sharifi Z; Dalimi A
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101413. PubMed ID: 31954995
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis).
Heath DD; Robinson C; Shakes T; Huang Y; Gulnur T; Shi B; Zhang Z; Anderson GA; Lightowlers MW
Vaccine; 2012 Apr; 30(20):3076-81. PubMed ID: 22406459
[TBL] [Abstract][Full Text] [Related]
20. [Cloning and epitope prediction of AgB antigen gene family of Echinococcus granulosus and Echinococcus multilocularis].
Jiang L; Feng Z; Hu W; Zhang YG
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):368-71, 376. PubMed ID: 21351551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
